Evidence map›Paper›PMID 34976114›Full record

ArticleComputational and mathematical methods in medicine2021

An Efficient Algorithm for the Detection of Outliers in Mislabeled Omics Data.

Hongwei Sun, Jiu Wang, Zhongwen Zhang, Naibao Hu, Tong Wang

Abstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hongwei SunDepartment of Health Statistics, School of Public Health and Management, Binzhou Medical University, Yantai City, Shandong 264003, China.ORCID https://orcid.org/0000-0001-7645-8593
Jiu WangDepartment of Health Statistics, School of Public Health and Management, Binzhou Medical University, Yantai City, Shandong 264003, China.
Zhongwen ZhangDepartment of Health Statistics, School of Public Health and Management, Binzhou Medical University, Yantai City, Shandong 264003, China.
Naibao HuDepartment of Health Statistics, School of Public Health and Management, Binzhou Medical University, Yantai City, Shandong 264003, China.
Tong WangDepartment of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan City, Shanxi 030001, China.ORCID https://orcid.org/0000-0002-9403-7167

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High dimensionality and noise have made it difficult to detect related biomarkers in omics data. Through previous study, penalized maximum trimmed likelihood estimation is effective in identifying mislabeled samples in high-dimensional data with mislabeled error. However, the algorithm commonly used in these studies is the concentration step (C-step), and the C-step algorithm that is applied to robust penalized regression does not ensure that the criterion function is gradually optimized iteratively, because the regularized parameters change during the iteration. This makes the C-step algorithm runs very slowly, especially when dealing with high-dimensional omics data. The AR-Cstep (C-step combined with an acceptance-rejection scheme) algorithm is proposed. In simulation experiments, the AR-Cstep algorithm converged faster (the average computation time was only 2% of that of the C-step algorithm) and was more accurate in terms of variable selection and outlier identification than the C-step algorithm. The two algorithms were further compared on triple negative breast cancer (TNBC) RNA-seq data. AR-Cstep can solve the problem of the C-step not converging and ensures that the iterative process is in the direction that improves criterion function. As an improvement of the C-step algorithm, the AR-Cstep algorithm can be extended to other robust models with regularized parameters.

Indexed as

AlgorithmsBiomarkersBiomarkers, TumorComputational BiologyComputer SimulationDatabases, GeneticFemaleGenomicsHumansLogistic ModelsMetabolomicsTriple Negative Breast NeoplasmsBiomarkersBiomarkers, Tumor

Identifiers

PMID34976114
PMCPMC8716222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.